Trial intelligence / Profile preview

Rebif vs Copaxone in Relapsing Remitting Multiple Sclerosis

NCT00078338Phase 4Completed

Sponsor
EMD Serono
Start
Feb 2004
Primary completion
Nov 2006
Modality
Cytokines & Interferons
Countries
12
01

Overview

A Phase 4 trial of interferon beta in relapsing-remitting multiple sclerosis (RRMS), sponsored by EMD Serono. Started Feb 2004; status: completed.

02

Drugs

interferon beta
03

Conditions

relapsing-remitting multiple sclerosis (RRMS)

Beyond the preview

Go deeper on NCT00078338.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00078338.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call